The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Ciclosporin Market Research Report 2025
Synopsis
The global Ciclosporin market was valued at US$ 23 million in 2023 and is anticipated to reach US$ 32 million by 2030, witnessing a CAGR of 4.8% during the forecast period 2024-2030.
The ciclosporin market is experiencing several key trends that are shaping its growth and development. 1. Increasing prevalence of autoimmune diseases: Ciclosporin is commonly used as an immunosuppressant in the treatment of various autoimmune diseases such as psoriasis, rheumatoid arthritis, and atopic dermatitis. The rising prevalence of these conditions is driving the demand for ciclosporin. Additionally, the expanding pool of patients with organ transplants, who require immunosuppressive therapy, is also contributing to the market growth.2. Growing research and development: There is ongoing research and development in the field of ciclosporin to explore its potential applications in new indications. This includes investigating its efficacy in treating other autoimmune disorders, such as lupus nephritis and inflammatory bowel disease. The continuous efforts to expand the therapeutic applications of ciclosporin are expected to drive market growth in the future.
This report aims to provide a comprehensive presentation of the global market for Ciclosporin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ciclosporin.
Report Scope
The Ciclosporin market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Ciclosporin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Ciclosporin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Mayne Pharma Group Limited
Sandoz
Novartis
Apotex
AbbVie
Novartis
Mylan
Teva Pharmaceutical Industries
Segment by Type
Oral Liquid
Capsule
Pill
Other
Segment by Application
Aplastic Anemia
Castleman Disease
Hemophagocytic Lymphohistiocytosis
Myelodysplastic Syndrome
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Ciclosporin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Ciclosporin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Ciclosporin market was valued at US$ 23 million in 2023 and is anticipated to reach US$ 32 million by 2030, witnessing a CAGR of 4.8% during the forecast period 2024-2030.
The ciclosporin market is experiencing several key trends that are shaping its growth and development. 1. Increasing prevalence of autoimmune diseases: Ciclosporin is commonly used as an immunosuppressant in the treatment of various autoimmune diseases such as psoriasis, rheumatoid arthritis, and atopic dermatitis. The rising prevalence of these conditions is driving the demand for ciclosporin. Additionally, the expanding pool of patients with organ transplants, who require immunosuppressive therapy, is also contributing to the market growth.2. Growing research and development: There is ongoing research and development in the field of ciclosporin to explore its potential applications in new indications. This includes investigating its efficacy in treating other autoimmune disorders, such as lupus nephritis and inflammatory bowel disease. The continuous efforts to expand the therapeutic applications of ciclosporin are expected to drive market growth in the future.
This report aims to provide a comprehensive presentation of the global market for Ciclosporin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ciclosporin.
Report Scope
The Ciclosporin market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Ciclosporin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Ciclosporin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Mayne Pharma Group Limited
Sandoz
Novartis
Apotex
AbbVie
Novartis
Mylan
Teva Pharmaceutical Industries
Segment by Type
Oral Liquid
Capsule
Pill
Other
Segment by Application
Aplastic Anemia
Castleman Disease
Hemophagocytic Lymphohistiocytosis
Myelodysplastic Syndrome
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Ciclosporin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Ciclosporin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Ciclosporin Market Overview
1.1 Product Overview and Scope of Ciclosporin
1.2 Ciclosporin Segment by Type
1.2.1 Global Ciclosporin Market Value Comparison by Type (2024-2030)
1.2.2 Oral Liquid
1.2.3 Capsule
1.2.4 Pill
1.2.5 Other
1.3 Ciclosporin Segment by Application
1.3.1 Global Ciclosporin Market Value by Application: (2024-2030)
1.3.2 Aplastic Anemia
1.3.3 Castleman Disease
1.3.4 Hemophagocytic Lymphohistiocytosis
1.3.5 Myelodysplastic Syndrome
1.4 Global Ciclosporin Market Size Estimates and Forecasts
1.4.1 Global Ciclosporin Revenue 2019-2030
1.4.2 Global Ciclosporin Sales 2019-2030
1.4.3 Global Ciclosporin Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Ciclosporin Market Competition by Manufacturers
2.1 Global Ciclosporin Sales Market Share by Manufacturers (2019-2024)
2.2 Global Ciclosporin Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Ciclosporin Average Price by Manufacturers (2019-2024)
2.4 Global Ciclosporin Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Ciclosporin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Ciclosporin, Product Type & Application
2.7 Ciclosporin Market Competitive Situation and Trends
2.7.1 Ciclosporin Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Ciclosporin Players Market Share by Revenue
2.7.3 Global Ciclosporin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Ciclosporin Retrospective Market Scenario by Region
3.1 Global Ciclosporin Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Ciclosporin Global Ciclosporin Sales by Region: 2019-2030
3.2.1 Global Ciclosporin Sales by Region: 2019-2024
3.2.2 Global Ciclosporin Sales by Region: 2025-2030
3.3 Global Ciclosporin Global Ciclosporin Revenue by Region: 2019-2030
3.3.1 Global Ciclosporin Revenue by Region: 2019-2024
3.3.2 Global Ciclosporin Revenue by Region: 2025-2030
3.4 North America Ciclosporin Market Facts & Figures by Country
3.4.1 North America Ciclosporin Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Ciclosporin Sales by Country (2019-2030)
3.4.3 North America Ciclosporin Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Ciclosporin Market Facts & Figures by Country
3.5.1 Europe Ciclosporin Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Ciclosporin Sales by Country (2019-2030)
3.5.3 Europe Ciclosporin Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Ciclosporin Market Facts & Figures by Country
3.6.1 Asia Pacific Ciclosporin Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Ciclosporin Sales by Country (2019-2030)
3.6.3 Asia Pacific Ciclosporin Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Ciclosporin Market Facts & Figures by Country
3.7.1 Latin America Ciclosporin Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Ciclosporin Sales by Country (2019-2030)
3.7.3 Latin America Ciclosporin Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Ciclosporin Market Facts & Figures by Country
3.8.1 Middle East and Africa Ciclosporin Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Ciclosporin Sales by Country (2019-2030)
3.8.3 Middle East and Africa Ciclosporin Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Ciclosporin Sales by Type (2019-2030)
4.1.1 Global Ciclosporin Sales by Type (2019-2024)
4.1.2 Global Ciclosporin Sales by Type (2025-2030)
4.1.3 Global Ciclosporin Sales Market Share by Type (2019-2030)
4.2 Global Ciclosporin Revenue by Type (2019-2030)
4.2.1 Global Ciclosporin Revenue by Type (2019-2024)
4.2.2 Global Ciclosporin Revenue by Type (2025-2030)
4.2.3 Global Ciclosporin Revenue Market Share by Type (2019-2030)
4.3 Global Ciclosporin Price by Type (2019-2030)
5 Segment by Application
5.1 Global Ciclosporin Sales by Application (2019-2030)
5.1.1 Global Ciclosporin Sales by Application (2019-2024)
5.1.2 Global Ciclosporin Sales by Application (2025-2030)
5.1.3 Global Ciclosporin Sales Market Share by Application (2019-2030)
5.2 Global Ciclosporin Revenue by Application (2019-2030)
5.2.1 Global Ciclosporin Revenue by Application (2019-2024)
5.2.2 Global Ciclosporin Revenue by Application (2025-2030)
5.2.3 Global Ciclosporin Revenue Market Share by Application (2019-2030)
5.3 Global Ciclosporin Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Mayne Pharma Group Limited
6.1.1 Mayne Pharma Group Limited Corporation Information
6.1.2 Mayne Pharma Group Limited Description and Business Overview
6.1.3 Mayne Pharma Group Limited Ciclosporin Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Mayne Pharma Group Limited Ciclosporin Product Portfolio
6.1.5 Mayne Pharma Group Limited Recent Developments/Updates
6.2 Sandoz
6.2.1 Sandoz Corporation Information
6.2.2 Sandoz Description and Business Overview
6.2.3 Sandoz Ciclosporin Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Sandoz Ciclosporin Product Portfolio
6.2.5 Sandoz Recent Developments/Updates
6.3 Novartis
6.3.1 Novartis Corporation Information
6.3.2 Novartis Description and Business Overview
6.3.3 Novartis Ciclosporin Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Novartis Ciclosporin Product Portfolio
6.3.5 Novartis Recent Developments/Updates
6.4 Apotex
6.4.1 Apotex Corporation Information
6.4.2 Apotex Description and Business Overview
6.4.3 Apotex Ciclosporin Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Apotex Ciclosporin Product Portfolio
6.4.5 Apotex Recent Developments/Updates
6.5 AbbVie
6.5.1 AbbVie Corporation Information
6.5.2 AbbVie Description and Business Overview
6.5.3 AbbVie Ciclosporin Sales, Revenue and Gross Margin (2019-2024)
6.5.4 AbbVie Ciclosporin Product Portfolio
6.5.5 AbbVie Recent Developments/Updates
6.6 Novartis
6.6.1 Novartis Corporation Information
6.6.2 Novartis Description and Business Overview
6.6.3 Novartis Ciclosporin Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Novartis Ciclosporin Product Portfolio
6.6.5 Novartis Recent Developments/Updates
6.7 Mylan
6.6.1 Mylan Corporation Information
6.6.2 Mylan Description and Business Overview
6.6.3 Mylan Ciclosporin Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Mylan Ciclosporin Product Portfolio
6.7.5 Mylan Recent Developments/Updates
6.8 Teva Pharmaceutical Industries
6.8.1 Teva Pharmaceutical Industries Corporation Information
6.8.2 Teva Pharmaceutical Industries Description and Business Overview
6.8.3 Teva Pharmaceutical Industries Ciclosporin Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Teva Pharmaceutical Industries Ciclosporin Product Portfolio
6.8.5 Teva Pharmaceutical Industries Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Ciclosporin Industry Chain Analysis
7.2 Ciclosporin Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Ciclosporin Production Mode & Process
7.4 Ciclosporin Sales and Marketing
7.4.1 Ciclosporin Sales Channels
7.4.2 Ciclosporin Distributors
7.5 Ciclosporin Customers
8 Ciclosporin Market Dynamics
8.1 Ciclosporin Industry Trends
8.2 Ciclosporin Market Drivers
8.3 Ciclosporin Market Challenges
8.4 Ciclosporin Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Ciclosporin Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Ciclosporin Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Ciclosporin Market Competitive Situation by Manufacturers in 2023
Table 4. Global Ciclosporin Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Ciclosporin Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Ciclosporin Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Ciclosporin Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Ciclosporin Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Ciclosporin, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Ciclosporin, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Ciclosporin, Product Type & Application
Table 12. Global Key Manufacturers of Ciclosporin, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Ciclosporin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ciclosporin as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Ciclosporin Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Ciclosporin Sales by Region (2019-2024) & (K Units)
Table 18. Global Ciclosporin Sales Market Share by Region (2019-2024)
Table 19. Global Ciclosporin Sales by Region (2025-2030) & (K Units)
Table 20. Global Ciclosporin Sales Market Share by Region (2025-2030)
Table 21. Global Ciclosporin Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Ciclosporin Revenue Market Share by Region (2019-2024)
Table 23. Global Ciclosporin Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Ciclosporin Revenue Market Share by Region (2025-2030)
Table 25. North America Ciclosporin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Ciclosporin Sales by Country (2019-2024) & (K Units)
Table 27. North America Ciclosporin Sales by Country (2025-2030) & (K Units)
Table 28. North America Ciclosporin Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Ciclosporin Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Ciclosporin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Ciclosporin Sales by Country (2019-2024) & (K Units)
Table 32. Europe Ciclosporin Sales by Country (2025-2030) & (K Units)
Table 33. Europe Ciclosporin Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Ciclosporin Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Ciclosporin Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Ciclosporin Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Ciclosporin Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Ciclosporin Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Ciclosporin Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Ciclosporin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Ciclosporin Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Ciclosporin Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Ciclosporin Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Ciclosporin Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Ciclosporin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Ciclosporin Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Ciclosporin Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Ciclosporin Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Ciclosporin Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Ciclosporin Sales (K Units) by Type (2019-2024)
Table 51. Global Ciclosporin Sales (K Units) by Type (2025-2030)
Table 52. Global Ciclosporin Sales Market Share by Type (2019-2024)
Table 53. Global Ciclosporin Sales Market Share by Type (2025-2030)
Table 54. Global Ciclosporin Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Ciclosporin Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Ciclosporin Revenue Market Share by Type (2019-2024)
Table 57. Global Ciclosporin Revenue Market Share by Type (2025-2030)
Table 58. Global Ciclosporin Price (US$/Unit) by Type (2019-2024)
Table 59. Global Ciclosporin Price (US$/Unit) by Type (2025-2030)
Table 60. Global Ciclosporin Sales (K Units) by Application (2019-2024)
Table 61. Global Ciclosporin Sales (K Units) by Application (2025-2030)
Table 62. Global Ciclosporin Sales Market Share by Application (2019-2024)
Table 63. Global Ciclosporin Sales Market Share by Application (2025-2030)
Table 64. Global Ciclosporin Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Ciclosporin Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Ciclosporin Revenue Market Share by Application (2019-2024)
Table 67. Global Ciclosporin Revenue Market Share by Application (2025-2030)
Table 68. Global Ciclosporin Price (US$/Unit) by Application (2019-2024)
Table 69. Global Ciclosporin Price (US$/Unit) by Application (2025-2030)
Table 70. Mayne Pharma Group Limited Corporation Information
Table 71. Mayne Pharma Group Limited Description and Business Overview
Table 72. Mayne Pharma Group Limited Ciclosporin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Mayne Pharma Group Limited Ciclosporin Product
Table 74. Mayne Pharma Group Limited Recent Developments/Updates
Table 75. Sandoz Corporation Information
Table 76. Sandoz Description and Business Overview
Table 77. Sandoz Ciclosporin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Sandoz Ciclosporin Product
Table 79. Sandoz Recent Developments/Updates
Table 80. Novartis Corporation Information
Table 81. Novartis Description and Business Overview
Table 82. Novartis Ciclosporin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Novartis Ciclosporin Product
Table 84. Novartis Recent Developments/Updates
Table 85. Apotex Corporation Information
Table 86. Apotex Description and Business Overview
Table 87. Apotex Ciclosporin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Apotex Ciclosporin Product
Table 89. Apotex Recent Developments/Updates
Table 90. AbbVie Corporation Information
Table 91. AbbVie Description and Business Overview
Table 92. AbbVie Ciclosporin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. AbbVie Ciclosporin Product
Table 94. AbbVie Recent Developments/Updates
Table 95. Novartis Corporation Information
Table 96. Novartis Description and Business Overview
Table 97. Novartis Ciclosporin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Novartis Ciclosporin Product
Table 99. Novartis Recent Developments/Updates
Table 100. Mylan Corporation Information
Table 101. Mylan Description and Business Overview
Table 102. Mylan Ciclosporin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Mylan Ciclosporin Product
Table 104. Mylan Recent Developments/Updates
Table 105. Teva Pharmaceutical Industries Corporation Information
Table 106. Teva Pharmaceutical Industries Description and Business Overview
Table 107. Teva Pharmaceutical Industries Ciclosporin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Teva Pharmaceutical Industries Ciclosporin Product
Table 109. Teva Pharmaceutical Industries Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Ciclosporin Distributors List
Table 113. Ciclosporin Customers List
Table 114. Ciclosporin Market Trends
Table 115. Ciclosporin Market Drivers
Table 116. Ciclosporin Market Challenges
Table 117. Ciclosporin Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Ciclosporin
Figure 2. Global Ciclosporin Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Ciclosporin Market Share by Type in 2023 & 2030
Figure 4. Oral Liquid Product Picture
Figure 5. Capsule Product Picture
Figure 6. Pill Product Picture
Figure 7. Other Product Picture
Figure 8. Global Ciclosporin Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Ciclosporin Market Share by Application in 2023 & 2030
Figure 10. Aplastic Anemia
Figure 11. Castleman Disease
Figure 12. Hemophagocytic Lymphohistiocytosis
Figure 13. Myelodysplastic Syndrome
Figure 14. Global Ciclosporin Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Ciclosporin Market Size (2019-2030) & (US$ Million)
Figure 16. Global Ciclosporin Sales (2019-2030) & (K Units)
Figure 17. Global Ciclosporin Average Price (US$/Unit) & (2019-2030)
Figure 18. Ciclosporin Report Years Considered
Figure 19. Ciclosporin Sales Share by Manufacturers in 2023
Figure 20. Global Ciclosporin Revenue Share by Manufacturers in 2023
Figure 21. The Global 5 and 10 Largest Ciclosporin Players: Market Share by Revenue in 2023
Figure 22. Ciclosporin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 23. Global Ciclosporin Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 24. North America Ciclosporin Sales Market Share by Country (2019-2030)
Figure 25. North America Ciclosporin Revenue Market Share by Country (2019-2030)
Figure 26. United States Ciclosporin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Canada Ciclosporin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. Europe Ciclosporin Sales Market Share by Country (2019-2030)
Figure 29. Europe Ciclosporin Revenue Market Share by Country (2019-2030)
Figure 30. Germany Ciclosporin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. France Ciclosporin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. U.K. Ciclosporin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Italy Ciclosporin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Russia Ciclosporin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Asia Pacific Ciclosporin Sales Market Share by Region (2019-2030)
Figure 36. Asia Pacific Ciclosporin Revenue Market Share by Region (2019-2030)
Figure 37. China Ciclosporin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Japan Ciclosporin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. South Korea Ciclosporin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. India Ciclosporin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Australia Ciclosporin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. China Taiwan Ciclosporin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Southeast Asia Ciclosporin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Ciclosporin Sales Market Share by Country (2019-2030)
Figure 45. Latin America Ciclosporin Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Ciclosporin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Ciclosporin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Ciclosporin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Ciclosporin Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa Ciclosporin Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Ciclosporin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Ciclosporin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. UAE Ciclosporin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Ciclosporin by Type (2019-2030)
Figure 55. Global Revenue Market Share of Ciclosporin by Type (2019-2030)
Figure 56. Global Ciclosporin Price (US$/Unit) by Type (2019-2030)
Figure 57. Global Sales Market Share of Ciclosporin by Application (2019-2030)
Figure 58. Global Revenue Market Share of Ciclosporin by Application (2019-2030)
Figure 59. Global Ciclosporin Price (US$/Unit) by Application (2019-2030)
Figure 60. Ciclosporin Value Chain
Figure 61. Ciclosporin Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
